Skip to content

actiTENS iOS app

by Sublimed

actiTENS iOS app (SBM2AA210) is a medical device (FDA Class II) made by Sublimed, cleared under FDA 510(k) K252767 on 16 Jan 2026 (1 earlier submission) and listed in FDA GUDID since 24 Apr 2024 (UDI-DI B786SBM2AA2100), active as of 2 Nov 2026.

Active United States. Also listed in GUDID (US).

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 2 Nov 2026

Documents

Trust

Unverified

Source GUDID, synced 2 Nov 2026.

Regulatory status

as of registry sync 2 Nov 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k) from GUDID NumberK252767 Date16 Jan 2026IssuedStatusActive
United StatesGUDID listing NumberB786SBM2AA2100 UDI-DI Date24 Apr 2024ListedStatusListed GUDID: in commercial distribution

Official records

From the FDA record

Device description
actiTENS is a transcutaneous electrical nerve stimulation (TENS) medical device designed to manage chronic pain. The compact design and flexible shape of the actiTENS electrical impulse generator allows to fix it for daily use directly to the body of the patient. The impulse generator is delivered with a separate cradle which allows safely recharging its non- removable battery. The actiTENS is compatible with a selection of disposable electrodes and compatible connector cables transmit the electrical stimulation impulses to the targeted nerves according to the selected therapy. The electrical stimulation waveforms are biphasic and asymmetric. The actiTENS is controlled via a downloadable mobile app which allows the comfortable and simple selection of the adequate stimulation program. The actiTENS is intended to be used by the patient at home and also for therapeutic application by medical professionals.
MRI safety
Labeling does not contain MRI Safety Information
Natural rubber latex
No latex statement on the label
Sterility
Supplied non-sterile

From the GUDID record (AccessGUDID), as read on 2 Nov 2026, as the labeller entered it.

Across registries

2 registries list this device

  • FDA 510(k) K252767 decided 16 Jan 2026 Active· +1 more in the status table
  • FDA GUDID UDI-DI B786SBM2AA2100 listed 24 Apr 2024 Listed

Timeline

3 dated events

  1. Cleared FDA 510(k) K202159
  2. Listed FDA GUDID B786SBM2AA2100
  3. Cleared FDA 510(k) K252767

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

GUDID

Trade name
actiTENS
Generic name
Analgesic transcutaneous electrical nerve stimulation system
Model / Ref / Catalog
actiTENS iOS app, SBM2AA210
Primary DI / UDI-DI
B786SBM2AA2100
510(k) Number
FDA product code
GZJ, IPF, NGX, NYN, NUH
GMDN term
Analgesic transcutaneous electrical nerve stimulation system
Device class
Class II
Regulation number
882.5890, 890.5850
GUDID distribution status
In Commercial Distribution

Similar devices in this category

Other devices filed under Analgesic transcutaneous electrical nerve stimulation system.

Other devices from Sublimed

See all devices from Sublimed →

Properties

  • Prescription use
  • Over-the-counter
  • Lot / batch number
Other properties (12, all answered No)